SEATTLE, Feb. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (CTIC) - Get Report today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a virtual meeting format.
Event: Cowen 41st Annual Health Care ConferenceDate: Thursday, Mar. 4, 2021Time: 12:10 p.m. EST
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.
About CTI BioPharma Corp.We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in Seattle, Washington.
CTI BioPharma Investor Contacts:
Maeve Conneighton/ Maghan Meyers
View original content to download multimedia: http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-cowen-41st-annual-health-care-conference-on-thursday-mar-4-301235382.html
SOURCE CTI BioPharma Corp.